Control Measures for Prevention of COPD
People with COPD have difficulty clearing their lungs of bacteria, dusts and other pollutants in the air. This makes them at risk for lung infections that may cause further damage to the lungs. Historically, acute toxicity was associated with occupational exposures to concentrations of soluble beryllium salts greater than 100 mg/m3. With the advent of industrial control measures to minimize air levels, acute pulmonary syndromes have virtually disappeared. In addition to environmental exposure, genetic predisposition seems to have a major role in the development of CBD. A variant of the human leukocyte antigen (HLA-DPb1 [Glu69]) is found in 80% to 97% of patients with CBD and in only 30%
- Agent Oriented Strategies
- Exposure Oriented Strategies
- Education and Training
Related Conference of Control Measures for Prevention of COPD
January 30-31, 2025
9th International Conference on Infectious Diseases: Control and Prevention
London, UK
May 21-22, 2025
12th International Conference on Infectious Diseases, Bacteriology and Antibiotics
Paris, France
June 16-17, 2025
5th International Conference on Microbiology and Infectious Diseases
Amsterdam, Netherlands
June 24-25, 2025
6th Annual Meeting on Infectious Diseases, Microbiology & Beneficial Microbes
Paris, France
October 06-07, 2025
13th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs
Las Vegas, USA
October 30-31, 2025
20th World Conference on Infectious Diseases, Prevention and Control
Paris, France
December 11-12, 2025
8th Annual Congress on Bacterial, Viral and Infectious Diseases
Prague, Czech Republic
November 4-7 2015 10th Annual New York Lung Cancer Symposium 2015
Indian Chest Society And The National College Of Chest Physicians 17th Joint National Conference 2015
Jaipur India
November 4-7 2015 10th Annual New York Lung Cancer Symposium 2015
Indian Chest Society And The National College Of Chest Physicians 17th Joint National Conference 2015
Jaipur India
November 4-7 2015
Indian Chest Society And The National College Of Chest Physicians 17th Joint National Conference 2015
Jaipur India
November 7 2015
10th Annual New York Lung Cancer Symposium 2015
New York United States
February 6-9 2016
X World Congress on Asthma COPD Immunopathology
Dubai UAE
April 13-16 2016
6th European Lung Cancer Conference
Geneva Switzerland
April 15-16 2016
Advance Diagnostic Bronchoscopy 2016
Florida United States
May 13-16 2016
International Conference of the American Thoracic Society
California USA
May 24-26 2016
Respiratory Health and Smoking Science Summit 2016
England UK
June 17-19 2016
International Pulmonary Hypertension Conference
Texas USA
October 15- 18 2016
30th Annual North American Cystic Fibrosis Conference
Florida USA
December 4- 5 2015
British Thoracic Society Winter Meeting 2016
London United Kingdom
Control Measures for Prevention of COPD Conference Speakers
Recommended Sessions
- Causes of COPD
- Diagnostic Techniques of COPD
- Pathophysiology of COPD
- Advancement in Lung Surgeries
- Clinical Evaluation of COPD
- Control Measures for Prevention of COPD
- COPD and Co-Morbidities
- COPD Health Care
- Developments in COPD Management
- Drugs Acting on COPD
- Lungs and its Functions; An Overview
- Multifaceted Mechanisms in COPD
- Pediatric COPD
- Pulmonary Rehabilitation for COPD
Related Journals
Are you interested in
- 1.Infectious Diseases and Neuro Infectious Diseases - Infectious Diseases_2025 (Canada)
- 10. HIV/AIDS - Infectious Diseases_2025 (Canada)
- 11. Pediatric Infectious Diseases/ Childhood Infectious Diseases - Infectious Diseases_2025 (Canada)
- 12. Respiratory Diseases - Infectious Diseases_2025 (Canada)
- 13. Sexually Transmitted Diseases/ Sexually Transmitted Infections - Infectious Diseases_2025 (Canada)
- 14. Viral Infectious Diseases - Infectious Diseases_2025 (Canada)
- 15. Malaria and Hepatitis - Infectious Diseases_2025 (Canada)
- 16. Immunology of Infections - Infectious Diseases_2025 (Canada)
- 17. Vaccines and Vaccination - Infectious Diseases_2025 (Canada)
- 18. Tuberculosis - Infectious Diseases_2025 (Canada)
- 19. New Antiviral, Antibacterial and Antifungal Agents - Infectious Diseases_2025 (Canada)
- 2. Coronavirus(nCOV) - Infectious Diseases_2025 (Canada)
- 20. Nosocomial Infections - Infectious Diseases_2025 (Canada)
- 21. Parasitic Diseases - Infectious Diseases_2025 (Canada)
- 22. Surgical Site Infections - Infectious Diseases_2025 (Canada)
- 3. Infectious Diseases Prevention, Control and Cure - Infectious Diseases_2025 (Canada)
- 4. Bacterial & Fungal Infectious Diseases - Infectious Diseases_2025 (Canada)
- 5. Rare Infectious Diseases and Immune Deficiencies - Infectious Diseases_2025 (Canada)
- 6. Rare Diseases in Cancer and Aging - Infectious Diseases_2025 (Canada)
- 7. Global Trends in Emerging Infectious Diseases - Infectious Diseases_2025 (Canada)
- 8. Ebola and Zika Viral Infections - Infectious Diseases_2025 (Canada)
- 9. Clinical Research and Public Awareness - Infectious Diseases_2025 (Canada)
- A prospective study of dermatological infections - Emerging Infectious Diseases 2025 (Canada)
- Advancement in the Diagnosis of Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Advancements in Vaccines and Therapeutics - Infectious Diseases 2025 (France)
- Antibiotics and Anti-viral - Euro Infectious Diseases 2025 (Netherlands)
- Antigen-Antibody Reactions - Infectious Diseases 2025 (France)
- Antimicrobial Resistance - Emerging Infectious Diseases 2025 (Canada)
- Antimicrobial Stewardship/Antimicrobial Resistance - Infection Prevention 2025 (UK)
- Bacterial Diseases - Euro Infectious Diseases 2025 (Netherlands)
- Bacterial Infections and Diseases - Infectious Diseases 2025 (France)
- Bacterial Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Bacterial Infectious Diseases - Infection Congress 2025 (Germany)
- Bacterial, Parasitic and Fungal Infections - Infection Prevention 2025 (UK)
- Biofertilizers - Infectious Diseases 2025 (France)
- Biomarkers for Rare Disease Diagnosis and Treatment - Rare Diseases Congress 2025 (Netherlands)
- Biomedical Research - Rare Diseases Congress 2025 (Netherlands)
- Blood Borne Infections/Sepsis/Septicaemia - Infection Prevention 2025 (UK)
- Bloodborne infectious diseases, - Infection Congress 2025 (Germany)
- Cardiovascular Diseases and Disorders - Emerging Infectious Diseases 2025 (Canada)
- Causes and Symptoms of Infections - Infection Prevention 2025 (UK)
- Causes and Symptoms of Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Challenges of Living with a Rare Disease - Rare Diseases Congress 2025 (Netherlands)
- Changing Patterns of Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Clinical analysis and Treatment - WORLD RARE DISEASES 2025 (Czech Republic)
- Clinical and Case Reports - INFECTIOUS DISEASES-2025 (France)
- Clinical Case Reports and Case Studies - Rare Diseases Congress 2025 (Netherlands)
- Clinical Management of Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Clinical Research on Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Coronavirus Disease (COVID-19) - INFECTIOUS DISEASES-2025 (France)
- COVID-19 - Infectious Diseases 2025 (France)
- COVID-19 Infection - Infection Congress 2025 (Germany)
- Covid_19 Infections - Infection Prevention 2025 (UK)
- Dental diseases & Infections - Emerging Infectious Diseases 2025 (Canada)
- Dermatological Infections - Euro Infectious Diseases 2025 (Netherlands)
- Diabetes and Wound Care - Emerging Infectious Diseases 2025 (Canada)
- Diagnosing infectious diseases - Infection Congress 2025 (Germany)
- Diagnosis of infectious Diseases - Infection Prevention 2025 (UK)
- Diagnostics and Laboratory Techniques - Emerging Infectious Diseases 2025 (Canada)
- Different Types of Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Disinfection and Sterilization - Infection Control 2025 (UK)
- Drug Discovery for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Ebola virus disease (EVD) & Zika virus - Infection Congress 2025 (Germany)
- Emerging and Re-Emerging Infections - Infection Congress 2025 (Germany)
- Emerging and Re-Emerging Infections - Infection Prevention 2025 (UK)
- Emerging Infectious Diseases - Infection Control 2025 (UK)
- Emerging Technologies in Rare Disease Research - Rare Diseases Congress 2025 (Netherlands)
- Epidemiology - INFECTIOUS DISEASES-2025 (France)
- Epidemiology - Infection Prevention 2025 (UK)
- Epidemiology and Surveillance - Emerging Infectious Diseases 2025 (Canada)
- Epidemiology of Infectious Diseases - Infection Congress 2025 (Germany)
- Food and waterborne Infections - Infection Congress 2025 (Germany)
- Functional Genomics and Gene Therapy for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Fungal Infections - Infectious Diseases 2025 (France)
- Fungal Infections - Euro Infectious Diseases 2025 (Netherlands)
- Fungal Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Fungal Infectious Diseases - Infection Congress 2025 (Germany)
- Gastrointestinal and urinary tract infections - Infection Congress 2025 (Germany)
- Gastrointestinal and Urinary Tract Infections - Infection Prevention 2025 (UK)
- Gene Expression - Infectious Diseases 2025 (France)
- Genetic Testing and Counselling of Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Global Climatic Change and Emerging Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Global Health Security - Emerging Infectious Diseases 2025 (Canada)
- Global hotspots and correlates of emerging zoonotic diseases - Emerging Infectious Diseases 2025 (Canada)
- Global Trends in Emerging Infections - Infection Prevention 2025 (UK)
- Health Economics and Market Access for Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Hepatitis Prevention - Infection Control 2025 (UK)
- Hepatitis Prevention - Infection Prevention 2025 (UK)
- HIV Prevention, Treatment and Cure - Infection Control 2025 (UK)
- Human Monkeypox: An Emerging Zoonosis - Emerging Infectious Diseases 2025 (Canada)
- Immunizations and Vaccination - Infection Prevention 2025 (UK)
- Infection Control Bacteriology - Infection Control 2025 (UK)
- Infection Control Business - Infection Control 2025 (UK)
- Infection Control in Critical Care - Infection Prevention 2025 (UK)
- Infection Control in Dental - Infection Control 2025 (UK)
- Infection Control Precautions - Infection Control 2025 (UK)
- Infection Control Procedures - Infection Prevention 2025 (UK)
- Infection Control Treatment & Diagnosis - Infection Control 2025 (UK)
- Infection Prevention and Control - Euro Infectious Diseases 2025 (Netherlands)
- Infection Prevention and Control - Infection Prevention 2025 (UK)
- Infection Treatment and Control - Infection Control 2025 (UK)
- Infection, Immunity and Inflammation - INFECTIOUS DISEASES-2025 (France)
- Infection, Immunity and Inflammation - INFECTIOUS DISEASES-2025 (France)
- Infectious Disease - Euro Infectious Diseases 2025 (Netherlands)
- Infectious Disease Pathology - Infection Control 2025 (UK)
- Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Infectious Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Infectious Diseases - Infection Congress 2025 (Germany)
- Infectious Diseases and Cancer - Infectious Diseases 2025 (France)
- Infectious Diseases and Immune Deficiencies - Rare Diseases Congress 2025 (Netherlands)
- Infectious Diseases Epidemiology - INFECTIOUS DISEASES-2025 (France)
- Infectious Diseases Prevention, Control and Cure - INFECTIOUS DISEASES-2025 (France)
- Influenza and Diagnostic Approaches - Infection Control 2025 (UK)
- Internal Medicine for Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Introduction and Causes of New Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Mutations - Infectious Diseases 2025 (France)
- Mystery designation of Rare Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Neglected Tropical Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Neuro infections - Infection Congress 2025 (Germany)
- Neuro Infections - Infection Prevention 2025 (UK)
- Neuro Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Neurological Infections - Euro Infectious Diseases 2025 (Netherlands)
- Nosocomial Infections & Control - Infection Control 2025 (UK)
- Nosocomial Infections & Control - INFECTIOUS DISEASES-2025 (France)
- Nosocomial Infections and Control - Infection Prevention 2025 (UK)
- Nosocomial Infections and Their Control Strategies - Emerging Infectious Diseases 2025 (Canada)
- Nursing Infection Control - Infection Control 2025 (UK)
- Ophthalmological Infections - Euro Infectious Diseases 2025 (Netherlands)
- Orphan Drugs Potentiality - Rare Diseases Congress 2025 (Netherlands)
- Orphan medicine - WORLD RARE DISEASES 2025 (Czech Republic)
- Outbreak Investigation and Response - Emerging Infectious Diseases 2025 (Canada)
- Paediatric Infectious Diseases - Euro Infectious Diseases 2025 (Netherlands)
- Parasitic Infections - Infectious Diseases 2025 (France)
- Parasitic Infections - Euro Infectious Diseases 2025 (Netherlands)
- Parasitic Infectious Diseases - Infection Congress 2025 (Germany)
- Parasitology & Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Pediatric Infectious Diseases - Infection Control 2025 (UK)
- Pediatric Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Pediatric Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Perspectives on Gastrointestinal Infections - Emerging Infectious Diseases 2025 (Canada)
- Pharmacology of Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Plants Diseases and Infection Control - Infection Prevention 2025 (UK)
- Practical Guidelines - Infection Control 2025 (UK)
- Practices & Awareness - Infection Control 2025 (UK)
- Preventive Measures - Euro Infectious Diseases 2025 (Netherlands)
- Prion Diseases - Infectious Diseases 2025 (France)
- Probiotics and Prebiotics - Infectious Diseases 2025 (France)
- Public Health - Euro Infectious Diseases 2025 (Netherlands)
- Public Health Policy and Preparedness - Emerging Infectious Diseases 2025 (Canada)
- Pulmonary and Chest Infections - Infection Congress 2025 (Germany)
- Pulmonary Infection Therapy - Infection Congress 2025 (Germany)
- Rare Autoimmune Disorders - Rare Diseases Congress 2025 (Netherlands)
- Rare Bone Diseases - Rare Diseases Congress 2025 (Netherlands)
- Rare Cancer - Rare Diseases Congress 2025 (Netherlands)
- Rare Cancer Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Diseases analysis - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Diseases and Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Rare Diseases in Brain - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Diseases of the Heart and Vessels - Rare Diseases Congress 2025 (Netherlands)
- Rare Endocrine Genetic Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Genetic Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare hematology Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Neurological Disorders - Rare Diseases Congress 2025 (Netherlands)
- Rare Nutritional and Metabolic Diseases - Rare Diseases Congress 2025 (Netherlands)
- Rare Paediatric Diseases - Rare Diseases Congress 2025 (Netherlands)
- Rare paediatrics Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare response Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Skin Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Skin Diseases - Rare Diseases Congress 2025 (Netherlands)
- Regulatory Considerations for Developing Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Research on Medicine and Vaccine for Covid-19 - INFECTIOUS DISEASES-2025 (France)
- Respiratory Infectious Diseases and Therapy - Infection Prevention 2025 (UK)
- Respiratory tract infections - Euro Infectious Diseases 2025 (Netherlands)
- Risk Factors & Prevention - Infection Control 2025 (UK)
- SARS and MERS: Recent Insights into Emerging Coronaviruses - Emerging Infectious Diseases 2025 (Canada)
- Sexually Transmitted Diseases (STDs) and Infections (STIs) - Infectious Diseases 2025 (France)
- Sexually transmitted diseases STDs - Infection Congress 2025 (Germany)
- The Science of SARS-CoV-2 - Emerging Infectious Diseases 2025 (Canada)
- Therapeutics and Treatment Strategies - Emerging Infectious Diseases 2025 (Canada)
- Treatment and Advanced Therapies for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Treatment for Rare Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Treatment for Tuberculosis - Infection Control 2025 (UK)
- Tropical diseases - Euro Infectious Diseases 2025 (Netherlands)
- Tropical Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Urinary Tract Infection - Euro Infectious Diseases 2025 (Netherlands)
- Vaccine Research & Development - Infection Control 2025 (UK)
- Vaccines - Euro Infectious Diseases 2025 (Netherlands)
- Vaccines and Immunization - Emerging Infectious Diseases 2025 (Canada)
- Vaccines and Vaccination - INFECTIOUS DISEASES-2025 (France)
- Vaccines and Vaccination for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Vector-borne diseases: New Approaches to Control Vector from disease transmission - Emerging Infectious Diseases 2025 (Canada)
- Veterinary Diseases - INFECTIOUS DISEASES-2025 (France)
- Veterinary Infection Control - Infection Control 2025 (UK)
- Veterinary Infectious Diseases - Infectious Diseases 2025 (France)
- Viral Infections - Euro Infectious Diseases 2025 (Netherlands)
- Viral Infections and Diseases - Infectious Diseases 2025 (France)
- Viral Infections and Recent Advancements - Infection Prevention 2025 (UK)
- Viral Infectious Diseases - INFECTIOUS DISEASES-2025 (France)